A team at Nashville, Tenn.-based Vanderbilt Heart and Vascular Institute successfully employed a robotic device to place a patient’s central line.
Vanderbilt Health is one of five centers selected by the FDA to study the Obvius Robotics device for central line placement, according to a March 18 news release.
Led by Aniket Rali, MD, co-director of the medical cardiovascular ICU, the team first used the device in January on a patient receiving a pulmonary artery pressure monitoring device.
“It basically does the job of what may take a human experience over 100 cases to perform with that level of precision and safety,” Dr. Rali said in the news release. “It makes the entire process of getting the needle into the blood vessel much more precise.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
